Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
ACK1
59%
Castration-resistant Prostate Cancer
45%
Phosphorylation
44%
TNK2
42%
Androgen Receptor
42%
Clear Cell Renal Cell Carcinoma (ccRCC)
38%
Essential Pathway
38%
Epigenetics
38%
Progression Markers
38%
Transcriptome Characterization
38%
Tyrosine Kinase
30%
Acetylation
26%
Reporting System
21%
Data Systems
21%
Therapeutic Vulnerability
20%
Aggressive Prostate Cancer
20%
Cytomorphology
19%
Conflict of Interest
19%
Androgen Production
19%
Potential Conflict
19%
Urinary Bladder Mass
19%
Insurance Medicine
19%
National Cancer Institute
19%
Competing Interests
19%
Bladder Mass
19%
Vulnerability
19%
Cdc42
19%
Histological Analysis
19%
Follicular Dendritic Cell Sarcoma
19%
Urinary Bladder
19%
Neuroendocrine Phenotype
19%
Endobronchial Ultrasound Guided
19%
Immune Checkpoint Blockade Resistance
19%
HOXB13
19%
N-linked
19%
ATP Synthase
19%
Matrix-assisted Laser Desorption Ionization (MALDI)
19%
Mass Spectrometry Imaging
19%
Artificial Intelligence Models
19%
Epigenetic Enzymes
19%
Cancer Immune Checkpoints
19%
Programmed Death-ligand 1 Expression
19%
Histone H3
19%
Therapeutic Targeting
19%
Clinical Proteomic Tumor Analysis Consortium (CPTAC)
19%
Mass-like Lesion
19%
Alpha Subunit
19%
Visium Spatial Transcriptomics
19%
A. Pipelines
19%
Biochemistry, Genetics and Molecular Biology
phosphorylation
46%
Androgen Receptor
45%
Transcriptomics
38%
Kinase
29%
Phosphotransferase
29%
Polysaccharide
25%
Matrix-Assisted Laser Desorption/Ionization
22%
Cancer Cell
20%
Enhancer Region
20%
Proteomics
20%
ATP Synthase
19%
Ferroxidase
19%
Ceruloplasmin
19%
Troponin I
19%
CDC42
19%
Alpha Chain
19%
HOXB13
19%
Immune Checkpoints
19%
C-Terminus
19%
Enzyme
19%
Histone H3
19%
Homeostasis
19%
Mass Spectrometry Imaging
19%
Artificial Intelligence
19%
Poly ADP Ribose Polymerase
19%
PARP1
19%
Recombination Repair
16%
Homologous Recombination
16%
Enzalutamide
12%
Carcinogenesis
11%
Tumor Progression
11%
Mitophagy
11%
Non-Receptor Tyrosine Kinase
11%
Magnetic Resonance Imaging
9%
Tyrosine
9%
Mitochondrion
7%
Troponin
7%
T Cell
6%
Acetylation
6%
Mesenchymal-Epithelial Transition
6%
PBRM1
6%
BAP1
6%
Proteogenomics
6%
Eosin
6%
Immunocompetent Cell
6%
Clinical Trial
6%
Extracellular Matrix Proteins
6%
Scleroprotein
6%
Fucosylation
6%
Fucose
6%
Medicine and Dentistry
Endobronchial Ultrasonography
38%
Biopsy Technique
31%
Immunohistochemistry
27%
Malignant Neoplasm
25%
Cytotechnology
25%
Fine-Needle Aspiration
25%
Non Small Cell Lung Cancer
23%
Transbronchial Aspiration
22%
Neoplasm
21%
Tumor Cell
19%
Prostate Cancer
19%
Lung Cancer
19%
Follicular Dendritic Cell Sarcoma
19%
Clear Cell Renal Cell Carcinoma
19%
Epithelial Cell Adhesion Molecule
19%
Plasmacytoma
19%
Bladder
19%
Transcriptomics
19%
Molecular Marker
19%
Proteomics
19%
Programmed Death 1 Ligand 1
19%
Artificial Intelligence
19%
Analysis of Variance
19%
Genetic Marker
19%
PI-RADS
16%
Effusion
14%
Carcinoma
14%
Hematopoietic System Malignancy
9%
Health Care Cost
9%
Lung
9%
Mediastinum Mass
9%
Cytopathology
9%
Odds Ratio
9%
Thyroid Gland
9%
Alcohol
9%
Epidermal Growth Factor Receptor
8%
Anaplastic Lymphoma Kinase
8%
Programmed Death-Ligand 1
8%
Reactive Oxygen Species
8%
Magnetic Resonance Imaging
7%
Lymphocyte
6%
Germinal Center
6%
Cytodiagnosis
6%
Comparative Analysis
6%
Follicular Dendritic Cells
6%
Diagnostic Error
6%
Tumor
6%
Immunophenotyping
6%
Liquid-Based Cytology
6%
Adenocarcinoma
5%